Half-dose rivaroxaban vs antiplatelet therapy for preventing silent cerebral embolism after left atrial appendage occlusion: the HALO-SCE trial - Kexin Wang; Linsheng Shi; Zhongbao Ruan; Hongwu Chen; Hailei Liu; Zidun Wang; Xiaohong Jiang; Mingfang Li; Minglong Chen; Weizhu Ju (European Heart Journal, 2026)